Restatement of Previously Issued Financial Statements - Schedule of Unaudited Condensed Consolidated Statements of Operations (Parenthetical) (Details) - USD ($) $ in Thousands |
3 Months Ended | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|||||||||||||||||
Condensed Income Statements, Captions [Line Items] | ||||||||||||||||||
Revenue | $ 34,825 | $ 23,217 | ||||||||||||||||
Cost of revenue | 25,596 | 13,369 | ||||||||||||||||
Research and development | 6,037 | 7,318 | ||||||||||||||||
General and administrative | 9,844 | 11,823 | ||||||||||||||||
Allowance for current expected credit loss on notes receivable | 40 | 0 | ||||||||||||||||
Proceeds from sale of notes receivable | 4,500 | |||||||||||||||||
Foreign exchange (loss) gain | (1,786) | 1,013 | ||||||||||||||||
Other (expense) income, net | (534) | (311) | ||||||||||||||||
Income tax (benefit) provision | (9) | 23 | ||||||||||||||||
Restatement Adjustments [Member] | ||||||||||||||||||
Condensed Income Statements, Captions [Line Items] | ||||||||||||||||||
Revenue | [1] | 9,137 | (951) | |||||||||||||||
Cost of revenue | [2] | 13,050 | 3,009 | |||||||||||||||
Construction costs and Launch costs | 9,178 | 642 | ||||||||||||||||
Research and development | [3] | (3,872) | (2,345) | |||||||||||||||
General and administrative | [4] | 26 | 53 | |||||||||||||||
Reclassification of state income tax | 17 | 450 | ||||||||||||||||
Reclassification of supply chain department costs | 22 | |||||||||||||||||
Allowance for current expected credit loss on notes receivable | [5] | 40 | 0 | |||||||||||||||
Proceeds from sale of notes receivable | 4,500 | |||||||||||||||||
Foreign exchange (loss) gain | [6] | (248) | (11) | |||||||||||||||
Other (expense) income, net | [7] | 17 | 451 | |||||||||||||||
Income tax (benefit) provision | [8] | (50) | (246) | |||||||||||||||
Research and Development Expense [Member] | Restatement Adjustments [Member] | ||||||||||||||||||
Condensed Income Statements, Captions [Line Items] | ||||||||||||||||||
Research and development | 3,872 | 2,345 | ||||||||||||||||
Delaware Franchise Tax [Member] | Restatement Adjustments [Member] | ||||||||||||||||||
Condensed Income Statements, Captions [Line Items] | ||||||||||||||||||
General and administrative | 9 | |||||||||||||||||
Reclassification of supply chain department costs | $ 20 | $ 377 | ||||||||||||||||
|
X | ||||||||||
- Definition Allowance For Credit Loss On Notes Receivable No definition available.
|
X | ||||||||||
- Definition Construction Costs And Launch Costs No definition available.
|
X | ||||||||||
- Definition Reclassification of State Income Tax No definition available.
|
X | ||||||||||
- Definition Reclassification of Supply Chain Department Costs No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cash inflow associated with the sale of a borrowing supported by a written promise to pay an obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|